Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery.
about
Nano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesMetabolic Functions of the Lung, Disorders and Associated PathologiesNaringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.Nanoparticle-mediated pulmonary drug delivery: a reviewKanamycin Sulphate Loaded PLGA-Vitamin-E-TPGS Long Circulating Nanoparticles Using Combined Coating of PEG and Water-Soluble Chitosan.Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer.
P2860
Q26786162-F6206C65-745E-45BF-BBB4-829CC62DC2FFQ28072037-99A3E671-99C1-4FC9-9BCB-F9CB2D063891Q36657570-52B21D95-A008-4F05-97E8-9FF88F3CBBFFQ38203377-BA35F33E-AD91-4B0F-B943-9E600C6B0513Q41822512-AD99B153-3857-44A1-9F83-F74251663CD0Q47122978-964C4A4B-8412-493E-9DB5-8E10E9451138Q48097759-73DC29A3-5499-4CCD-861F-60D50A8D13F3
P2860
Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery.
@en
type
label
Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery.
@en
prefLabel
Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery.
@en
P2093
P2860
P50
P356
P1476
Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery.
@en
P2093
J Varshosaz
S F Mirshojaei
S Ghaffari
P2860
P304
P356
10.1155/2013/136859
P407
P577
2013-08-01T00:00:00Z